Squarepoint Ops LLC Aurinia Pharmaceuticals Inc. Transaction History

Squarepoint Ops LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $31,763 - $41,441	3,545 Added 18.28%	22,941 $222,000
Q1 2023 May 15, 2023	SELL	$5.94 - $11.27 $120,385 - $228,409	-20,267 Reduced 51.1%	19,396 $212,000
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $19,181 - $37,989	4,667 Added 13.34%	39,663 $171,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $233,073 - $433,600	34,996 New	34,996 $263,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $2.03 Million - $2.91 Million	-227,114 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $1.36 Million - $3.03 Million	134,933 Added 146.38%	227,114 $2.81 Million
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $825,489 - $1.54 Million	46,428 Added 101.48%	92,181 $2.11 Million
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $500,080 - $1.08 Million	45,753 New	45,753 $1.01 Million
Q2 2020 Aug 14, 2020	SELL	$14.12 - $18.33 $495,386 - $643,089	-35,084 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $67,915 - $128,523	5,989 Added 20.58%	35,084 $509,000
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $112,888 - $623,214	29,095 New	29,095 $589,000

223

59.4M

1.17M

1.54M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.13B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.